XALAMOL

This brand name is authorized in Australia, Hong Kong

Active ingredients

The drug XALAMOL contains a combination of these active pharmaceutical ingredients (APIs):

1 Latanoprost
UNII 6Z5B6HVF6O - LATANOPROST

The active substance latanoprost, a prostaglandin F analogue, is a selective prostanoid FP receptor agonist which reduces the intraocular pressure (IOP) by increasing the outflow of aqueous humour. Reduction of the IOP in man starts about three to four hours after administration and maximum effect is reached after eight to twelve hours.

Read about Latanoprost
2 Timolol
UNII 817W3C6175 - TIMOLOL

Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.

Read about Timolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S01EE Prostaglandin analogues S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics
Discover more medicines within S01EE

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 5553G, 8895E
Country: HK Department of Health Drug Office Identifier(s): 64161

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.